Alina Kotlyar

发表

Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers.

Stefan Vogt, Seungpyo Hong, Christopher Kelly, 2008, ACS nano.

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

Thommey P. Thomas, Alina Kotlyar, Anil K Patri, 2006, Bioconjugate chemistry.

Sustained Analgesia Achieved Through Esterase-Activated Morphine Prodrugs Complexed with PAMAM Dendrimer

Thommey P. Thomas, Xiangyang Shi, P. Leroueil, 2012, Pharmaceutical Research.

Quantification of Dendrimer Nanoparticle Targeting on Tumor Cells by Two-photon Excitation Fluorescence through a Dual-Clad Optical Fiber

Thommey P. Thomas, T. Norris, I. Majoros, 2008 .

Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.

Thommey P. Thomas, M. B. Banaszak Holl, B. Orr, 2013, ACS chemical biology.

Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.

Thommey P. Thomas, I. Majoros, P. Leroueil, 2011, Arthritis and rheumatism.

Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery.

Thommey P. Thomas, S. Choi, J. Baker, 2010, Bioorganic & medicinal chemistry letters.

Targeting and inhibition of cell growth by an engineered dendritic nanodevice.

Thommey P. Thomas, I. Majoros, J. Baker, 2005, Journal of medicinal chemistry.

Plasma-mediated release of morphine from synthesized prodrugs.

Thommey P. Thomas, P. Leroueil, J. Baker, 2010, Bioorganic & medicinal chemistry letters.

Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations.

Thommey P. Thomas, I. Majoros, M. Holl, 2009, Biomacromolecules.

Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.

Thommey P. Thomas, Yueyang Zhong, M. B. Banaszak Holl, 2011, Bioconjugate chemistry.

Dendrimer-epidermal growth factor conjugate displays superagonist activity.

Thommey P. Thomas, T. Norris, J. Baker, 2008, Biomacromolecules.

Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.

Thommey P. Thomas, S. Choi, J. Baker, 2013, Current pharmaceutical design.

Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate

Thommey P. Thomas, S. Choi, J. Baker, 2012, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate.

Thommey P. Thomas, S. Choi, J. Baker, 2010, Chemical communications.

Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.

Thommey P. Thomas, Jeremy J Gam, Jeremy J. Gam, 2012, Molecular pharmaceutics.

Association of Variants in TMEM45A With Keratoglobus.

O. de Backer, N. Shomron, E. Pras, 2021, JAMA ophthalmology.

Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement

S. Swanson, J. Baker, A. Patri, 2008, International journal of nanomedicine.

Dendrimer-based tumor cell targeting of fibroblast growth factor-1.

Thommey P. Thomas, J. Baker, R. Shukla, 2010, Bioorganic & medicinal chemistry letters.